Wedbush Securities’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Wedbush Securities's BLUE Position: Q3 2019 in Review
Wedbush Securities sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 176 shares — an estimated $290K sold.
Wedbush Securities first reported a position in BLUE in Q2 2014 and held it in 20 quarters. The position peaked at $671K in Q2 2015. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.
- Wedbush Securities reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
- Wedbush Securities sold 176 bluebird bio shares in Q3 2019, an estimated $290K.
- Wedbush Securities first reported a position in bluebird bio in Q2 2014 and held it in 20 quarters.
- Wedbush Securities's bluebird bio position peaked at $671K in Q2 2015.
- 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.
Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.